Nifty
:
26013.45
Sensex
:
84950.95
103.40 (0.40%)
388.17 (0.46%)
Nifty
Sensex
:
:
26013.45
84950.95
103.40 (0.40%)
388.17 (0.46%)

Max Healthcare Institute Ltd.

Hospital & Healthcare Services

Rating :
62/99

BSE: 543220 | NSE: MAXHEALTH

NSE BSE
1121.60
17-Nov-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1105
  •  1124.8
  •  1091.7
  •  1103.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  5102278
  •  5664442639.1
  •  1314.3
  •  936.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,09,099.45
  • 80.39
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,11,319.26
  • 0.13%
  • 10.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.74%
  • 0.22%
  • 3.08%
  • FII
  • DII
  • Others
  • 51.8%
  • 17.83%
  • 3.33%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.14
  • 22.89
  • 15.49

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.88
  • 36.84
  • 8.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -0.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 75.36
  • 78.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.83
  • 9.57

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 46.29
  • 48.00

Earnings Forecasts:

(Updated: 08-11-2025)
Description
2024
2025
2026
2027
Adj EPS
11.07
18.2
23.24
28.05
P/E Ratio
101.32
61.63
48.26
39.99
Revenue
6910.36
10517.6
12609.2
14748.2
EBITDA
1848.8
2797.42
3489.4
4178.8
Net Income
1075.88
1752.6
2238.39
2706.97
ROA
7.91
11.04
12.56
13.92
P/B Ratio
11.62
9.11
7.76
6.63
ROE
12.1
16.44
17.7
18.31
FCFF
492.72
46.09
1005.34
2235.74
FCFF Yield
0.42
0.04
0.85
1.9
Net Debt
2328.4
1875.82
1313.72
-380.79
BVPS
96.5
123.12
144.51
169.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
2,135.47
1,707.46
25.07%
2,027.57
1,542.95
31.41%
1,909.74
1,422.90
34.21%
1,868.31
1,334.97
39.95%
Expenses
1,560.32
1,256.92
24.14%
1,504.66
1,155.54
30.21%
1,398.12
1,040.24
34.40%
1,369.18
949.11
44.26%
EBITDA
575.15
450.54
27.66%
522.91
387.41
34.98%
511.62
382.66
33.70%
499.13
385.86
29.36%
EBIDTM
26.93%
26.39%
25.79%
25.11%
26.79%
26.89%
26.72%
28.90%
Other Income
32.90
40.84
-19.44%
36.51
34.68
5.28%
46.92
44.12
6.35%
33.30
46.02
-27.64%
Interest
53.92
33.54
60.76%
54.85
23.88
129.69%
55.21
20.73
166.33%
52.39
11.24
366.10%
Depreciation
108.10
84.15
28.46%
104.14
76.90
35.42%
100.83
70.32
43.39%
97.54
60.96
60.01%
PBT
446.03
373.69
19.36%
400.43
321.31
24.62%
402.50
335.73
19.89%
308.87
359.68
-14.13%
Tax
-45.27
91.88
-
92.46
85.04
8.73%
83.50
84.19
-0.82%
70.07
70.34
-0.38%
PAT
491.30
281.81
74.34%
307.97
236.27
30.35%
319.00
251.54
26.82%
238.80
289.34
-17.47%
PATM
23.01%
16.50%
15.19%
15.31%
16.70%
17.68%
12.78%
21.67%
EPS
5.05
2.90
74.14%
3.17
2.43
30.45%
3.28
2.59
26.64%
2.46
2.98
-17.45%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 16
Mar 15
Mar 14
Net Sales
7,941.09
7,028.46
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,445.40
1,133.61
944.46
Net Sales Growth
32.17%
30.01%
18.49%
15.90%
56.96%
136.82%
-37.37%
16.99%
27.50%
20.03%
 
Cost Of Goods Sold
1,711.38
1,477.05
1,118.52
922.01
922.90
594.41
217.31
364.46
398.63
345.95
328.00
Gross Profit
6,229.71
5,551.41
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,046.77
787.66
616.46
GP Margin
78.45%
78.98%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
72.42%
69.48%
65.27%
Total Expenditure
5,832.28
5,188.03
3,924.88
3,335.14
2,998.14
2,124.34
965.45
1,545.51
1,329.79
1,058.39
914.52
Power & Fuel Cost
-
115.03
77.54
69.04
62.67
51.37
22.72
46.06
40.73
32.60
29.63
% Of Sales
-
1.64%
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.82%
2.88%
3.14%
Employee Cost
-
1,174.01
934.40
809.35
759.92
588.78
230.13
440.55
297.48
232.09
188.81
% Of Sales
-
16.70%
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
20.58%
20.47%
19.99%
Manufacturing Exp.
-
1,800.27
1,348.42
1,195.50
995.21
670.35
336.05
112.01
16.97
293.99
244.08
% Of Sales
-
25.61%
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
1.17%
25.93%
25.84%
General & Admin Exp.
-
507.53
382.92
303.70
226.23
165.14
129.84
563.52
476.29
142.24
114.53
% Of Sales
-
7.22%
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
32.95%
12.55%
12.13%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
28.30
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
1.96%
0%
0%
Miscellaneous Exp.
-
114.14
63.08
35.54
31.21
54.29
29.40
18.91
99.69
11.52
0.00
% Of Sales
-
1.62%
1.17%
0.78%
0.79%
2.16%
2.78%
1.12%
6.90%
1.02%
1.00%
EBITDA
2,108.81
1,840.43
1,481.14
1,227.46
938.41
383.63
93.58
145.51
115.61
75.22
29.94
EBITDA Margin
26.56%
26.19%
27.40%
26.90%
23.84%
15.30%
8.84%
8.60%
8.00%
6.64%
3.17%
Other Income
149.63
164.01
189.05
152.31
131.51
134.97
48.08
66.72
29.78
27.27
23.48
Interest
216.37
165.02
59.89
83.86
100.87
179.46
83.24
101.27
73.06
61.16
62.25
Depreciation
410.61
359.42
244.98
232.19
221.12
174.09
45.64
102.64
86.62
78.38
55.46
PBT
1,557.83
1,480.00
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-14.29
-37.05
-64.29
Tax
200.76
330.49
307.68
-39.79
133.85
45.85
-0.13
8.51
-0.02
0.00
0.36
Tax Rate
12.89%
23.50%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
0.14%
0.00%
-0.56%
PAT
1,357.07
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-13.77
-37.05
-64.65
PAT before Minority Interest
1,357.07
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-14.27
-37.05
-64.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
0.50
0.00
0.00
PAT Margin
17.09%
15.31%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-0.95%
-3.27%
-6.85%
PAT Growth
28.15%
1.72%
-4.16%
82.38%
-
-
-
-
-
-
 
EPS
13.96
11.07
10.88
11.35
6.22
-1.18
0.13
-0.03
-0.14
-0.38
-0.66

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
9,380.87
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
Share Capital
972.14
971.91
970.92
969.61
965.95
537.24
537.24
Total Reserves
8,289.06
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
Non-Current Liabilities
3,991.80
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
Secured Loans
2,270.06
1,060.33
496.08
628.91
842.32
105.73
889.10
Unsecured Loans
0.00
0.50
0.50
0.50
0.50
0.50
0.96
Long Term Provisions
98.07
75.47
60.48
59.79
60.19
40.66
18.02
Current Liabilities
1,813.77
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
Trade Payables
807.92
633.01
543.46
444.11
435.69
179.63
291.59
Other Current Liabilities
863.43
493.26
408.16
196.95
237.52
95.26
752.87
Short Term Borrowings
63.59
61.29
45.58
74.53
54.25
727.37
77.61
Short Term Provisions
78.83
61.15
48.37
41.68
49.47
7.69
17.96
Total Liabilities
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
Net Block
11,496.93
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
Gross Block
13,337.72
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
Accumulated Depreciation
1,840.79
1,181.77
919.67
742.02
562.84
401.21
365.00
Non Current Assets
13,593.87
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
Capital Work in Progress
900.72
553.04
252.43
151.12
26.93
27.55
87.02
Non Current Investment
2.89
2.12
0.51
0.51
0.51
0.00
0.51
Long Term Loans & Adv.
951.31
727.51
673.93
757.17
679.63
70.06
535.51
Other Non Current Assets
237.36
227.40
193.21
262.46
175.54
109.71
91.83
Current Assets
1,592.57
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
Current Investments
0.00
0.00
0.00
0.00
0.00
2,182.06
0.00
Inventories
106.21
79.84
76.23
61.36
53.80
26.80
26.01
Sundry Debtors
687.31
462.69
336.12
385.36
365.89
96.09
362.61
Cash & Bank
681.89
1,099.27
1,468.07
499.31
652.92
119.57
11.64
Other Current Assets
117.16
23.46
14.06
23.99
51.86
490.87
47.04
Short Term Loans & Adv.
75.91
40.92
48.59
30.27
37.39
478.76
36.06
Net Current Assets
-221.20
457.47
897.50
243.02
347.54
1,905.44
-692.73
Total Assets
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,459.31
1,121.67
1,284.13
740.52
117.86
77.09
88.95
PBT
1,406.37
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
498.29
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-124.41
-159.22
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
1,780.25
1,390.95
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-320.94
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,631.74
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-307.51
-450.46
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-698.35
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-625.88
-394.37
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
-163.80
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
-336.23
-427.52
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
979.84
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
661.24
979.71
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
95.27
85.82
75.89
64.57
58.10
47.52
17.93
ROA
7.91%
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
12.22%
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
14.67%
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.60
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
29.86
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
4.83
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
178.04
191.96
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-143.35
-159.72
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.27
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
9.52
23.80
13.68
8.33
0.62
1.15
1.08

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Max Healthcare Institute reports 74% jump in Q2 consolidated net profit
    15th Nov 2025, 13:02 PM

    The consolidated total income of the company increased by 24.03% at Rs 2,168.37 crore for Q2FY26

    Read More
  • Max Healthcare Inst - Quarterly Results
    13th Aug 2025, 12:19 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.